Ƶ

Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia

— News and commentary from the endocrinology world

Ƶ MedicalToday
Endo Break over a computer rendering of a man with illustrated body organs.

All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken . (Reuters)

This prompted a for removing the drug from said list. (Reuters)

Meanwhile, the agency on the legal restrictions for making copies of approved drugs for compounders. Certain dosages of the GLP-1 receptor agonists dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy), and liraglutide (Victoza, Saxenda) are still in shortage.

Bothersome menopause symptoms like hot flashes in patients' electronic health records after primary care visits, according to a retrospective review. (Menopause)

Teva Pharmaceuticals announced of octreotide acetate for injectable suspension (Sandostatin LAR Depot) for the treatment of acromegaly.

Treatment with was superior to standard of care for healing deep diabetic foot ulcer wounds at 16 weeks, a randomized trial found. (NEJM Evidence)

The is hosting its first-ever Artificial Intelligence in Healthcare Virtual Summit in November, which will explore AI's potential to revolutionize patient care and shape the future of medicine.

A U.K. woman's dementia for 2 years. (BBC News)

Teva Pharmaceuticals' biosimilar candidate to the osteoporosis drug denosumab (Prolia) , the company said.

In a randomized trial of older women with type 2 diabetes, twice-daily treatment with for 1 year was linked to increases in the bone formation marker P1NP, bone density at the femoral neck, and a decrease in HbA1c. (Journal of Clinical Endocrinology & Metabolism)

is adding a compounded version of semaglutide to its weight management program.

NPR spoke with activists arguing for a .

The "obesity first" healthcare movement is treat chronic conditions. (Washington Post)

Digital voice analysis using broad acoustic analysis and machine learning more accurately than 12 experienced endocrinologists in a Swedish study. (Journal of Clinical Endocrinology & Metabolism)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.